Author: de Maat M.P.M. Kluft C.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.39, Iss.3, 2002-08, pp. : 137-139
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Coronary artery disease, inflammation and the ghost of John Hunter
Inflammopharmacology, Vol. 11, Iss. 3, 2003-09 ,pp. :
Role of inflammatory markers in coronary artery disease
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
By Thomas M. Narang D. Lakshmy R. Gupta R. Naik N. Maulik S.
Cardiovascular Drugs and Therapy, Vol. 20, Iss. 1, 2006-02 ,pp. :
By Boudoulas H Georgiadou P Iliodromitis EK Varounis C Mavroidis M Kolokathis F Andreadou I Psarras S Capetanaki Y Kremastinos D Th
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. :